The effects of dopamine on digit span in Parkinson’s disease

BACKGROUND: Parkinson’s disease patients are at an elevated risk of developing cognitive impairment. Although cognitive impairment is one of the strongest predictors of quality of life, dopaminergic anti-parkinsonian medications are designed to target motor symptoms. However, there is substantial ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Warden, Clara, Hwang, Jaclyn, Marshall, Anisa, Fenesy, Michelle, Poston, Kathleen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780147/
https://www.ncbi.nlm.nih.gov/pubmed/26955482
http://dx.doi.org/10.1186/s40734-016-0033-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780147/
https://www.ncbi.nlm.nih.gov/pubmed/26955482
http://dx.doi.org/10.1186/s40734-016-0033-z

Ejemplares similares